Clinical Trial Update: Evaluation of the Efficacy and Safety of a Paclitaxel Eluting PTCA Balloon Catheter in Coronary In-stent Restenosis [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/phase 3 trial evaluating the efficacy and safety of a paclitaxel-eluting PTCA balloon catheter for coronary in-stent restenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary In-stent Restenosis

Drugs mentioned

• Paclitaxel-eluting PTCA-balloon catheter (paclitaxel-eluting balloon catheter)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Coronary In-stent Restenosis | Phase 2, Phase 3 | Status: UNKNOWN